Opinion statement Melanoma is caused by a variety of somatic mutations, and among these
mutations, BRAF mutation occurs most frequently and has routinely been evaluated as a …

Melanoma is one of the most aggressive and progressive skin cancers. It develops from
normal pigment-producing cells known as melanocytes, so it is important to know the …

Malignant melanoma is the most lethal type of skin cancer with high rates of mortality.
Although current treatment options provide a short-clinical benefit, acquired-drug resistance …

Simple Summary Drug resistance is an obstacle to cancer therapy, and the underlying
mechanisms are still being explored. CC chemokine ligand-2 (CCL2) is one of the key …

Simple Summary Despite major recent therapeutic advances, melanoma remains the
deadliest form of skin cancer due to the capacity of melanoma cells to adapt to drug …

The genetic landscape of melanoma resistance to targeted therapy with small molecules
inhibiting BRAF and MEK kinases is still largely undefined. In this study, we portrayed in …

Melanoma is the most aggressive form of skin cancer resulting from genetic mutations in
melanocytes. Several factors have been considered to be involved in melanoma …

While multiplexing samples using DNA barcoding revolutionized the pace of biomedical
discovery, multiplexing of live imaging-based applications has been limited by the number of …

Thyroid cancer (TC) is a common endocrine cancer with a rising incidence. Current
treatment fails to eliminate aggressive thyroid tumours, prompting an investigation into the …

Melanoma tumors are highly immunogenic, making them an attractive target for
immunotherapy. However, many patients do not mount robust clinical responses to targeted …